12 April 2022

The precedent cases in recent years have shown that accelerating the inclusion of orphan drugs in the HA Drug Formulary and Safety Net is feasible. Therefore, RDHK hopes that the Government and the authorities concerned will learn from the successful experience and consider adopting the seven measures recommended below to optimise and regularise the access mechanism for orphan drugs.

Submission PDF (CHI): Download